Rikiya Taoka

32PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPacific Peoples social determinants of healthLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 18, 2026
Association Between Early Perioperative Fentanyl Exposure and Dose-Normalized Tacrolimus Exposure After Kidney Transplantation.

|Sep 03, 2026
Prophylactic intravenous dexamethasone is associated with reduced cutaneous toxicity during first-line enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma: a multicenter prospective cohort study.

|Feb 02, 2026
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan.

Keita Kobayashi, Kei Daizumoto, Takuya Tsujino

|Jan 31, 2026
Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched Analysis.

Yohei Abe, Rikiya Taoka, Asuka Kaji

|Jan 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study.

Sayaka Shimizu, Takahiro Osawa, Miho Sato

|Dec 26, 2025
Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial.

Rikiya Taoka, Hideo Fukuhara, Makito Miyake

Pageof 6

Frequent Collaborators

13 joint publications

Mikio Sugimoto

8 joint publications

Makito Miyake

7 joint publications

Yoichiro Tohi

7 joint publications

Kiyohide Fujimoto